생명과학용 IT 시장 : 기회 및 전략(-2035년)

Life Sciences information technology (IT) refers to the application of information technology systems, software, and digital infrastructure to support operations in the pharmaceutical, biotechnology, medical device, and healthcare sectors. The primary purpose of Life Sciences IT is to enable efficient data management, regulatory compliance, and digital transformation across research, development, manufacturing, and commercialization processes.

The life sciences IT market consists of sales by entities (organizations, sole traders and partnerships) of life sciences IT primarily used by pharmaceutical companies, biotechnology firms, contract research organizations, research laboratories, healthcare institutions and regulatory bodies to manage scientific data, streamline research workflows, improve collaboration and ensure compliance with regulatory standards. These solutions are used throughout the lifecycle of life sciences activities, from early-stage drug discovery and preclinical research to clinical trials, regulatory submissions, manufacturing and post-market surveillance. It includes solutions such as laboratory information management systems (LIMS), clinical trial management systems (CTMS), electronic lab notebooks (ELN), bioinformatics platforms, data analytics tools, cloud computing, and cybersecurity systems tailored to regulated environments.

The global life sciences IT market was valued at $16,428.1 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 12.00%.

Increasing Pharmaceutical Research And Development (R&D) Spending

During the historic period, the life sciences IT market was driven by increasing pharmaceutical research and development (R&D) spending. As pharmaceutical companies and biotechnology organizations expanded investments in drug discovery, clinical trials and advanced therapeutic research, the demand for digital technologies capable of managing complex research data, supporting collaborative scientific workflows and accelerating drug development processes increased significantly. For instance, in February 2025, according to International Federation of Pharmaceutical Manufacturers & Associations, a Switzerland-based global organization representing the research-based pharmaceutical industry, reported that the top 50 pharmaceutical companies alone were estimated to have spent a total of USD 167 billion in R&D in 2022, with R&D spending increasing by almost 60% over the ten-year period from 2012 to 2022. Therefore, the life sciences IT market was driven by increasing pharmaceutical research and development (R&D) spending during the historic period.

Integration Of Quantum Computing And Advanced Computational Platforms In Life Sciences

Companies operating in the life sciences IT market are increasingly focusing on the development of quantum computing, enabled research platforms, advanced computational chemistry tools and integrated digital discovery environments. These innovations combine high-performance computing, quantum simulation technologies and advanced modeling tools to enable more accurate analysis of complex chemical reactions, support faster molecular design and reduce the time required for pharmaceutical and materials development. For instance, in August 2025, Mitsui & Co., Ltd., a Japan-based diversified trading and investment company involved in advanced technology and innovation initiatives, partnered with QSimulate, a US-based computational chemistry software company and Quantinuum, a US-based quantum computing technology company, to launch QIDO (Quantum-Integrated Discovery Orchestrator), a quantum-integrated chemistry platform designed to accelerate research and development in drug and materials discovery. The platform combines advanced classical computing with quantum computing capabilities to enable high-precision chemical reaction modeling, streamline hybrid quantum-classical workflows and help organizations reduce the time and cost associated with developing new drugs and advanced materials.

The global life sciences IT market is fairly fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 18.51% of the total market in 2024.

Life Sciences IT Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global life sciences IT market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for life sciences IT? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The life sciences IT market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider life sciences IT market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segments, key products, supply chain and market attractiveness scoring and analysis.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market
• Growth Analysis And Strategic Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
• Regional And Country Analysis- Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by type, by solution and by end user in the market. Historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Recent Developments Information on recent developments in the market covered in the report.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for life sciences IT providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Type: Software; Service
• 2) By Solution: Drug Discovery Informatics; Clinical Trial Management; Bioinformatics; Laboratory Information Management; Other Solutions
• 3) By End User: Pharmaceutical And Biotechnology Companies; Contract Research And Development Organizations; Other End Users
• Companies Mentioned: IQVIA Holdings Inc; Oracle Corp; Accenture plc; Veeva Systems; SAP SE.
• Countries: China; Germany; Japan; UK; France; India; USA; Canada; South Korea; Brazil; Australia; Russia; Spain; Italy; Indonesia; Taiwan
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; life sciences IT indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.""""""""""""""""""""""""""""""""

Table of Contents

1 Executive Summary

• 1.1 Dashboard

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Life Sciences IT Market Definition And Segmentations
• 6.4 Market Segmentation By Type (Software And Service)
• 6.5 Market Segmentation By Solution (Drug Discovery Informatics, Clinical Trial Management, Bioinformatics, Laboratory Information Management and Other Solutions)
• 6.6 Market Segmentation By End User (Pharmaceutical And Biotechnology Companies, Contract Research And Development Organizations And Other End Users)

7 Life Sciences IT Market, Overview Of Key Products/Services

• 7.1 Life Sciences Information Technology (IT) Market, Overview Of Key Products/Services
• 7.2 Global Life Sciences IT Market Attractiveness Scoring And Analysis
  • 7.2.1 Overview Of Market Attractiveness Framework
  • 7.2.2 Quantitative Scoring Methodology
  • 7.2.3 Market Attractiveness Scoring And Interpretation
  • 7.2.4 Factor-Wise Evaluation
  • 7.2.5 Strategic Implications And Recommendations

8 Major Market Trends

• 8.1 Key Technologies & Future Trends
  • 8.1.1 Artificial Intelligence (AI) And Autonomous Intelligence
  • 8.1.2 Biotechnology, Genomics And Precision Medicine
  • 8.1.3 Industry 4.0 And Intelligent Manufacturing
  • 8.1.4 Internet of Things (IoT), Smart Infrastructure And Connected Ecosystem
  • 8.1.5 Digitalization, Cloud, Big Data And Cybersecurity
• 8.2 Major Trends
  • 8.2.1 Integration Of Quantum Computing And Advanced Computational Platforms In Life Sciences
  • 8.2.2 Adoption Of AI-Driven Commercialization And Marketing Automation Platforms
  • 8.2.3 Development Of Cloud-Based Inspection And AI-Driven Manufacturing Analytics Platforms
  • 8.2.4 Expansion Of Cloud-Based Engagement And Data Integration Platforms

9 Life Sciences IT Growth Analysis And Strategic Analysis Framework

• 9.1 Global Life Sciences IT PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
  • 9.1.1 Political
  • 9.1.2 Economic
  • 9.1.3 Social
  • 9.1.4 Technological
  • 9.1.5 Environmental
  • 9.1.6 Legal
• 9.2 Analysis Of End User (B2B) Market
  • 9.2.1 Pharmaceutical And Biotechnology Companies
  • 9.2.2 Contract Research and Development Organizations (CROs)
  • 9.2.3 Other End Users (Healthcare Providers, Government Agencies & Diagnostics Firms)

10 Global Life Sciences IT Market Size And Growth Analysis

• 10.1 Historic Market Growth, 2020 - 2025, Value ($ Million)
  • 10.1.1 Market Drivers 2020 - 2025
  • 10.1.2 Market Restraints 2020 - 2025
• 10.2 Forecast Market Growth, 2025 - 2030, 2035F Value ($ Million)
• 10.3 Forecast Growth Contributors/Factors
  • 10.3.1 Quantitative Growth Contributors
  • 10.3.2 Drivers
  • 10.3.3 Restraints

11 Global Life Sciences IT Total Addressable Market (TAM) Analysis

• 11.1 Definition And Scope of Total Addressable Market (TAM)
• 11.2 Methodology And Assumptions
  • 11.2.1 Total Addressable Market for the Life Sciences IT Market - Business to Customer (B2C)

12 Global Life Sciences IT Market Segmentation

• 12.1 Global Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.2 Global Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.3 Global Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.4 Global Life Sciences IT Market, Sub-Segmentation Of Software, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.5 Global Life Sciences IT Market, Sub-Segmentation Of Services, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

13 Life Sciences IT Market, Regional and Country Analysis

• 13.1 Global Life Sciences IT Market, By Region, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.2 Global Life Sciences IT Market, By Country, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

14 Asia-Pacific Market

• 14.1 Asia-Pacific Market Summary
• 14.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 14.3 Asia Pacific Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.4 Asia Pacific Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.5 Asia Pacific Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.6 China Market
  • 14.6.1 China Market Summary
  • 14.6.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 14.6.3 China Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.6.4 China Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.6.5 China Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.7 India Market
  • 14.7.1 India Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.7.2 India Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.7.3 India Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.8 Japan Market
  • 14.8.1 Japan Market Summary
  • 14.8.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 14.8.3 Japan Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.8.4 Japan Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.8.5 Japan Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.9 Australia Market
  • 14.9.1 Australia Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.9.2 Australia Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.9.3 Australia Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.10 South Korea Market
• 14.11 South Korea Market Summary
  • 14.11.1 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
  • 14.11.2 South Korea Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.11.3 South Korea Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.11.4 South Korea Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.12 Taiwan Market
• 14.13 Taiwan Market Summary
  • 14.13.1 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
  • 14.13.2 Taiwan Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.13.3 Taiwan Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.13.4 Taiwan Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

15 South East Asia Market

• 15.1 South East Asia Market Summary
• 15.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
  • 15.2.1 South East Asia Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.2.2 South East Asia Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.2.3 South East Asia Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.3 Indonesia Market
  • 15.3.1 Indonesia Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.3.2 Indonesia Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.3.3 Indonesia Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

16 Western Europe Market

• 16.1 Western Europe Market Summary
• 16.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 16.3 Western Europe Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.4 Western Europe Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.5 Western Europe Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.6 UK Market
  • 16.6.1 UK Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.6.2 UK Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.6.3 UK Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.7 Germany Market
  • 16.7.1 Germany Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.7.2 Germany Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.7.3 Germany Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.8 France Market
  • 16.8.1 France Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.8.2 France Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.8.3 France Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.9 Italy Market
  • 16.9.1 Italy Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.9.2 Italy Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.9.3 Italy Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.10 Spain Market
  • 16.10.1 Spain Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.10.2 Spain Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.10.3 Spain Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

17 Eastern Europe Market

• 17.1 Eastern Europe Market Summary
• 17.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 17.3 Eastern Europe Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.4 Eastern Europe Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.5 Eastern Europe Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.6 Russia Market
  • 17.6.1 Russia Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.6.2 Russia Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.6.3 Russia Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

18 North America Market

• 18.1 North America Market Summary
• 18.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 18.3 North America Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.4 North America Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.5 North America Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.6 USA Market
  • 18.6.1 USA Market Summary
  • 18.6.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 18.6.3 USA Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.6.4 USA Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.6.5 USA Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.7 Canada Market
  • 18.7.1 Canada Market Summary
  • 18.7.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
  • 18.7.3 Canada Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.7.4 Canada Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.7.5 Canada Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

19 South America Market

• 19.1 South America Market Summary
• 19.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 19.3 South America Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.4 South America Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.5 South America Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.6 Brazil Market
  • 19.6.1 Brazil Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.6.2 Brazil Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.6.3 Brazil Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

20 Middle East Market

• 20.1 Middle East Market Summary
• 20.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 20.3 Middle East Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.4 Middle East Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.5 Middle East Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

21 Africa Market

• 21.1 Africa Market Summary
• 21.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 21.3 Africa Life Sciences IT Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.4 Africa Life Sciences IT Market, Segmentation By Solution, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.5 Africa Life Sciences IT Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

22 Competitive Landscape And Company Profiles

• 22.1 Life Sciences IT Market Competitive Landscape And & Market Share 2024
  • 22.1.1 Top 10 Companies (Ranked by revenue/share)
• 22.2 Company Profiles
• 22.3 IQVIA Holdings Inc. (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 22.4 Oracle Corp. (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 22.5 Accenture plc (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 22.6 Veeva Systems (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 22.7 SAP SE (Company Overview, Products and Services, Business Strategy, Financial Overview)

23 Other Major And Innovative Companies

• 23.1 International Business Machines Corp. (Company Overview, Products and Services)
• 23.2 Cognizant Technology Solutions Corporation (Company Overview, Products and Services)
• 23.3 SAS Institute Inc. (Statistical Analysis System) (Company Overview, Products and Services)
• 23.4 Dassault Systems SE (Medidata Solution Inc.) (Company Overview, Products and Services)
• 23.5 Persistent Systems (Company Overview, Products and Services)
• 23.6 Microsoft Corporation (Company Overview, Products and Services)
• 23.7 Agilent Technologies Inc. (Company Overview, Products and Services)
• 23.8 Siemens Healthineers AG (Company Overview, Products and Services)
• 23.9 PerkinElmer Inc. (Company Overview, Products and Services)
• 23.10 ArisGlobal LLC (Company Overview, Products and Services)
• 23.11 INFOR (Company Overview, Products and Services)
• 23.12 Koninklijke Philips N.V. (Healthcare division) (Company Overview, Products and Services)
• 23.13 Fujitsu Ltd. (Company Overview, Products and Services)
• 23.14 LabWare Inc. (Company Overview, Products and Services)
• 23.15 Benchling Inc. (Company Overview, Products and Services)

24 Competitive Benchmarking

25 Competitive Dashboard

26 Life Sciences IT Market - Company Scoring Matrix

• 26.1 Innovation & Brand Leaders
• 26.2 Brand-Driven Traditionalists
• 26.3 Niche or Regional Followers
• 26.4 Emerging Innovators

27 Upcoming Startups In the Market

28 Key Mergers And Acquisitions

• 28.1 Siemens AG Acquired Dotmatics
• 28.2 Recursion Pharmaceuticals Inc. Acquired Exscientia plc
• 28.3 Ennov Acquired DocShifter

29 Recent Developments In The Life Sciences IT Market

• 29.1 Introduction Of AI-Powered Real-World Data Analytics And Conversational Research Platforms
• 29.2 Launch Of Cloud-Native Bio-simulation Workflow Automation Platforms

30 Opportunities And Strategies

• 30.1 Global Life Sciences IT Market In 2030 - Countries Offering Most New Opportunities
• 30.2 Global Life Sciences IT Market In 2030 - Segments Offering Most New Opportunities
• 30.3 Global Life Sciences IT Market In 2030 - Growth Strategies
  • 30.3.1 Market Trend Based Strategies
  • 30.3.2 Competitor Strategies

31 Life Sciences IT Market, Conclusions And Recommendations

• 31.1 Conclusions
• 31.2 Recommendations
  • 31.2.1 Product
  • 31.2.2 Place
  • 31.2.3 Price
  • 31.2.4 Promotion
  • 31.2.5 People

32 Appendix

• 32.1 Geographies Covered
• 32.2 Market Data Sources
• 32.3 Research Methodology
• 32.4 Currencies
• 32.5 The Business Research Company
• 32.6 Copyright and Disclaimer